Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-06 Sale | 2024-03-07 4:43 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 40,665 | $5.51 | $224,064 | 584,072 (Direct) | View |
| 2022-11-21 Purchase | 2022-11-23 4:04 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Internal Operations | 10,000 | $4.66 | $46,600 | 27,927 (Direct) | View |
| 2022-03-02 Sale | 2022-03-04 4:12 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations | 3,052 | $12.01 | $36,655 | 298,367 (Direct) | View |
| 2021-05-11 Purchase | 2021-05-12 4:34 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations | 9,900 | $10.07 | $99,739 | 9,900 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-20 Option Award | 2024-02-22 4:31 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 216,666 | $0 | 624,737 (Direct) | View |
| 2023-03-02 Option Award | 2023-03-06 4:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell EVP, Ops & Strategy | 271,134 | $0 | 403,141 (Direct) | View |
| 2022-03-02 Option Award | 2022-03-04 4:12 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations | 290,643 | $0 | 298,367 (Direct) | View |
Ownership | 2021-01-04 5:48 pm | N/A 2029-08-19 | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Ex VP, Intern'l Operations | 0 | $0 | 613,452 (Direct) | View |